NUTRA PHARMA CORP Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Nutra Pharma Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2022.
  • Nutra Pharma Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was $577K, a 96.3% decline year-over-year.
  • Nutra Pharma Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was $7.07M.
  • Nutra Pharma Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$13.1M, a 1603% decline from 2020.
  • Nutra Pharma Corp annual Net Income (Loss) Attributable to Parent for 2020 was -$769K, a 88.3% increase from 2019.
  • Nutra Pharma Corp annual Net Income (Loss) Attributable to Parent for 2019 was -$6.59M, a 69.7% decline from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $7.07M $577K -$14.9M -96.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-21
Q2 2022 $21.9M -$646K -$4.01M -119% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-22
Q1 2022 $25.9M $5.01M +$39M Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-20
Q4 2021 -$13.1M $2.13M +$4.16M Oct 1, 2021 Dec 31, 2021 10-K 2022-04-15
Q3 2021 -$17.3M $15.4M +$14.8M +2526% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$32.1M $3.36M +$4.87M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 -$37M -$34M -$36.2M -1658% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-20
Q4 2020 -$769K -$2.03M +$2M +49.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$2.77M $588K +$1.07M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$3.85M -$1.51M +$162K +9.69% Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-24
Q1 2020 -$4.01M $2.18M +$2.58M Jan 1, 2020 Mar 31, 2020 10-Q 2021-09-17
Q4 2019 -$6.59M -$4.04M -$3.45M -586% Oct 1, 2019 Dec 31, 2019 10-K 2021-09-08
Q3 2019 -$3.14M -$487K +$481K +49.7% Jul 1, 2019 Sep 30, 2019 10-Q 2021-08-12
Q2 2019 -$3.63M -$1.67M -$337K -25.4% Apr 1, 2019 Jun 30, 2019 10-Q 2021-08-05
Q1 2019 -$3.29M -$400K +$597K +59.9% Jan 1, 2019 Mar 31, 2019 10-Q 2021-07-23
Q4 2018 -$3.88M -$588K +$403K +40.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-07-01
Q3 2018 -$4.29M -$968K +$13.5K +1.38% Jul 1, 2018 Sep 30, 2018 10-Q 2021-05-14
Q2 2018 -$4.3M -$1.33M -$216K -19.3% Apr 1, 2018 Jun 30, 2018 10-Q 2021-05-07
Q1 2018 -$4.09M -$998K -$57.5K -6.11% Jan 1, 2018 Mar 31, 2018 10-Q 2021-04-05
Q4 2017 -$4.03M -$992K +$82.9K +7.72% Oct 1, 2017 Dec 31, 2017 10-K 2021-02-05
Q3 2017 -$4.11M -$981K -$337K -52.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-19
Q2 2017 -$3.77M -$1.12M -$461K -70.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-17
Q1 2017 -$3.31M -$940K +$135K +12.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$3.45M -$1.07M -$1.75M -259% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$1.7M -$644K +$3.29M +83.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 -$4.99M -$654K +$1.11M +63% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$6.1M -$1.07M -$711K -195% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-17
Q4 2015 -$5.39M $676K +$1.48M Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 -$6.87M -$3.94M -$3.73M -1821% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-22
Q2 2015 -$3.14M -$1.77M -$447K -33.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-22
Q1 2015 -$2.69M -$364K -$157K -75.9% Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-06-21
Q4 2014 -$2.53M -$802K -$188K -30.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-04-14
Q3 2014 -$2.34M -$205K +$2.44M +92.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-23
Q2 2014 -$4.79M -$1.32M -$710K -117% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-18
Q1 2014 -$4.08M -$207K +$266K +56.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-19
Q4 2013 -$4.34M -$614K +$1.47M +70.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-04-13
Q3 2013 -$5.82M -$2.65M -$2.34M -774% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$3.47M -$609K -$475K -354% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$3M -$473K +$615K +56.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-20
Q4 2012 -$3.61M -$2.09M +$412K +16.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$4.02M -$303K +$359K +54.2% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-19
Q2 2012 -$4.38M -$134K +$464K +77.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-19
Q1 2012 -$4.85M -$1.09M -$450K -70.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-20
Q4 2011 -$4.4M -$2.5M Oct 1, 2011 Dec 31, 2011 10-Q 2013-05-20
Q3 2011 -$662K -$21K -3.28% Jul 1, 2011 Sep 30, 2011 10-Q/A 2012-12-12
Q2 2011 -$598K +$757K +55.9% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-12-07
Q1 2011 -$638K Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-11-28
Q3 2010 -$641K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-15
Q2 2010 -$1.35M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.